可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Echt DS,Liebson PR,Mitchell LB,et al.Mortality and morrbidity in patients receiving encainide,flecainide or placebo.The cardiac arrhythmia suppressioon trial[J].N Engl J Med.1991,324:781-787.
[2]Th Cardiac Arrthythmio Suppression Trial II investigators.Effact of the antiarrhythmic agent moricizine on survival after myocardial infarction[J].N Engl J Med.1992,327:227-233.
[3]Waldo AL,Carom AJ,DeRuyter H,et al.Effect of d-sotelol on mortality in patients with left ventricular dysfuction after recent and remote myocardial infarction[J].Lancet,1996,348:7-12.
[4]Guerra PC, Talajic M,Roy D,et al.Is there a future for antiarrhythmic durg therapy?[J].Drugs.1998.56:767-781.
[5]Nattel S,Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs[J].Cardiovasc Res,1998,37:567-577.
[6]Wijffels MCEF,Kirchhof CJHJ,Dorland R,et al. Atrial fibril1ation begets atrial fibfillation:A study in awake chronically instrumented goats[J]. Circulation,1995,92:1965-1968.
[7]Xu YQ,Pickoff AS,Clarkson CW.Developmental changes in the effects of lidocaine on sodium channels in rat cardiac myocytes[J].J Pharmacol Exp Ther,1992,262:670-676.
[8]Swynghedauw B.Molecular mechanisms of myocardial remodeling[J].Physiol Rev,1999,79:215-268.
[9] Hondeghem LM.Ideal antiarrhymic agents:Chemical defribrillators[J].J Cardiovasc Electrophysol,1991,2:S169-S177.
[10] Shaw RM,Rudy Y.The vulnarable window for unidirectional block in cardiac tissue: Characterization and dependence on membrane excitability and intercellular coupling [J].J Cardiovasx Electrophysiol,l995,6:115-131.
[11]Carlsson L,Abrahamsson C,Andersson B,et al.Proarrhythmic effects of the class III agent almoskalant:Importance of infusion rate,QT dispersion,and early afterdepolarizations[J].Cardiovasc Res,1993,27:2186-2193.
[12]Carmeliet E.Use-dependent block sad use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes[J].Circ Res,1993,73:857-868.
[13]Camm AI,Yap YG.What should we expect from the next generation of antiarrhythmic durgs?[J].J Cardiovasc Electrophysiol,1999,10:307-317.
[14] Nattel S.The molecular and ionic specificity of antiarrhythmic drug actions[J].J Cardiovasc Electrophysiol,1999,10:272-282.
[15] Carmeliet E.Antiarrhythmic drugs and ion chennels,Have we made the connection?[J].J Cardiovasc Electrophysiol,1999,19:755-59.